GlassScriptPhysician profile
Randall S Starcher
NPI 1184712325
$8,043.60
in general payments reported to CMS, 2019-2025
22 companies · $231 in 2025
The $231 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,034 · 2020: $267 · 2021: $771 · 2022: $73.33 · 2023: $324 · 2024: $342 · 2025: $231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $897.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $897.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $6,169.36 | 2019-2024 | Myosure Tissue Removal Device |
| Lupin INC. | $600.00 | 2021 | |
| Abbvie INC. | $175.56 | 2019-2021 | |
| Caldera Medical, INC | $175.43 | 2019 | |
| Sage Therapeutics, LLC | $136.46 | 2023-2025 | Zurzuvae |
| Minerva Surgical, INC | $122.13 | 2023 | |
| Organon LLC | $100.73 | 2024-2025 | Nexplanon, Jada System |
| Medtronic, INC. | $98.67 | 2021-2025 | Interstim |
| Mayne Pharma Commercial LLC | $90.79 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $73.74 | 2023-2024 | Myfembree, Gemtesa |
| Exeltis, USA INC. | $69.13 | 2023-2025 | Slynd |
| Astellas Pharma US INC | $49.21 | 2023-2025 | Veozah |
| Meditrina | $28.98 | 2023-2025 | |
| Becton, Dickinson and Company | $21.15 | 2024 | Arista Ah Flexitip |
| Vertex Pharmaceuticals Incorporated | $20.47 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $20.00 | 2022 | |
| Exact Sciences Corporation | $17.50 | 2025 | Cologuard Collection Kit |
| Coloplast Corp | $16.66 | 2023 | Altis |
| Avion Pharmaceuticals | $15.71 | 2023 | Balcoltra |
| Axonics, INC. | $15.68 | 2022 | |
| Avation Medical, INC. | $14.32 | 2024 | Vivally |
| Duchesnay USA Incorporated | $11.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Starcher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.